Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 67551-67600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06014424
Cannabidiol Medication Intervention Trial
PHASE2Recruiting
40 participants
Started: Sep 27, 2023 · Completed: Dec 29, 2026
1 condition2 sponsors5 locations
NCT05945641
Effect of Low-load Resistance Training vs. High-intensity Interval Training on Local Muscle Endurance
NARecruiting
20 participants
Started: Sep 27, 2023 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT06056869
Effect of Hyoscine- Bromide on Duration of the First Stage of Labor
NARecruiting
60 participants
Started: Sep 27, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT06012149
Braining: Implementation of Physical Exercise for Patients in Specialist Psychiatry
NAActive, not recruiting
208 participants
Started: Sep 27, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors5 locations
NCT05902078
Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis
PHASE4Recruiting
300 participants
Started: Sep 27, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors21 locations
NCT05867433
Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments
NARecruiting
500 participants
Started: Sep 27, 2023 · Completed: Apr 15, 2027
3 conditions2 sponsors1 location
NCT06561100
Treatment Optimization of Brain-injured Warfighters
NARecruiting
140 participants
Started: Sep 27, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06184867
Choices About Genetic Testing And Learning Your Risk With Smart Technology
NAActive, not recruiting
45 participants
Started: Sep 26, 2023 · Completed: Sep 11, 2025
8 conditions1 sponsor1 location
NCT06144008
ESCAPE (Evaluating Surge Capacity And PrEparedness)
N/AEnrolling by invitation
3,000 participants
Started: Sep 26, 2023 · Completed: Nov 30, 2023
2 conditions1 sponsor1 location
NCT06043817
First-In-Human Study of STX-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
PHASE1/PHASE2Recruiting
185 participants
Started: Sep 26, 2023 · Completed: Jun 1, 2028
3 conditions1 sponsor21 locations
NCT05970692
Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale
N/ARecruiting
100 participants
Started: Sep 26, 2023 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT05461326
Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCT
NARecruiting
100 participants
Started: Sep 26, 2023 · Completed: Jun 30, 2030
2 conditions1 sponsor1 location
NCT05519007
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
NARecruiting
936 participants
Started: Sep 26, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors3 locations
NCT05380856
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
NARecruiting
60 participants
Started: Sep 26, 2023 · Completed: Mar 1, 2027
6 conditions4 sponsors1 location
NCT05789264
Nasal Compression Device Study for Epistaxis
NARecruiting
40 participants
Started: Sep 26, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06128798
Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.
NARecruiting
58 participants
Started: Sep 26, 2023 · Completed: Sep 25, 2024
1 condition1 sponsor1 location
NCT06247592
Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients
NARecruiting
70 participants
Started: Sep 26, 2023 · Completed: Apr 10, 2024
3 conditions1 sponsor1 location
NCT05715281
Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial
PHASE2Active, not recruiting
15 participants
Started: Sep 26, 2023 · Completed: Oct 15, 2026
3 conditions1 sponsor3 locations
NCT06007677
A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
PHASE2Active, not recruiting
56 participants
Started: Sep 26, 2023 · Completed: Mar 31, 2031
1 condition1 sponsor22 locations
NCT05812924
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause
PHASE2Recruiting
20 participants
Started: Sep 26, 2023 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT06105970
Chinese Community Sample of Hierarchical Model of Psychopathology
N/ARecruiting
4,000 participants
Started: Sep 26, 2023 · Completed: Nov 1, 2027
2 conditions1 sponsor1 location
NCT06045494
The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21
NAActive, not recruiting
140 participants
Started: Sep 26, 2023 · Completed: Jan 30, 2024
1 condition1 sponsor1 location
NCT06302777
MAIN-IMAGE Registry
N/ARecruiting
500 participants
Started: Sep 26, 2023 · Completed: Sep 26, 2031
1 condition1 sponsor2 locations
NCT06070051
Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy
PHASE1Active, not recruiting
56 participants
Started: Sep 26, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors3 locations
NCT06022250
The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant Tumor
PHASE1Active, not recruiting
98 participants
Started: Sep 26, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06019676
Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients
N/AActive, not recruiting
170 participants
Started: Sep 26, 2023 · Completed: Apr 1, 2027
1 condition2 sponsors12 locations
NCT05756569
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
PHASE2Recruiting
25 participants
Started: Sep 26, 2023 · Completed: Dec 16, 2027
11 conditions5 sponsors4 locations
NCT05890352
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
PHASE2Recruiting
227 participants
Started: Sep 26, 2023 · Completed: Jan 31, 2029
6 conditions5 sponsors104 locations
NCT05993923
Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer
N/ARecruiting
90 participants
Started: Sep 26, 2023 · Completed: Oct 31, 2028
2 conditions1 sponsor4 locations
NCT06528366
Heart Failure With Reduced Ejection Fraction: Adjuvant Therapy With Neurostimulation and Chlorella Pyrenoidosa (HD-tDCS)
NAActive, not recruiting
28 participants
Started: Sep 26, 2023 · Completed: Aug 30, 2024
2 conditions2 sponsors1 location
NCT06604000
Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury
NARecruiting
116 participants
Started: Sep 26, 2023 · Completed: Jan 1, 2030
2 conditions2 sponsors1 location
NCT06019000
Study of CYR-064 Versus Placebo in Patients.
PHASE2Active, not recruiting
150 participants
Started: Sep 26, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor14 locations
NCT05903092
MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer
PHASE2Recruiting
38 participants
Started: Sep 26, 2023 · Completed: Jan 3, 2027
3 conditions3 sponsors4 locations
NCT06044051
Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma
NARecruiting
100 participants
Started: Sep 26, 2023 · Completed: Sep 26, 2026
2 conditions1 sponsor1 location
NCT05785819
A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia
PHASE2Recruiting
60 participants
Started: Sep 26, 2023 · Completed: Mar 31, 2025
2 conditions1 sponsor14 locations
NCT05780021
Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation
NARecruiting
150 participants
Started: Sep 26, 2023 · Completed: Sep 26, 2026
1 condition1 sponsor1 location
NCT05937295
FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition
PHASE1Recruiting
20 participants
Started: Sep 26, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor1 location
NCT06150352
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
N/ARecruiting
180 participants
Started: Sep 26, 2023 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT06099197
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals
NARecruiting
40 participants
Started: Sep 26, 2023 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT06036121
A Study of ADRX-0706 in Select Advanced Solid Tumors
PHASE1Active, not recruiting
144 participants
Started: Sep 26, 2023 · Completed: Dec 31, 2026
4 conditions1 sponsor21 locations
NCT05863312
REtinal Detachment Outcomes Study
NARecruiting
560 participants
Started: Sep 26, 2023 · Completed: Jul 31, 2028
1 condition2 sponsors1 location
NCT06097104
Electrolytes Disturbances in Critically Ill Egyptian Patients
N/AEnrolling by invitation
110 participants
Started: Sep 26, 2023 · Completed: Aug 8, 2024
1 condition1 sponsor1 location
NCT06165900
Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC
PHASE2Recruiting
136 participants
Started: Sep 26, 2023 · Completed: Dec 15, 2028
3 conditions1 sponsor1 location
NCT05985330
Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
N/ARecruiting
56 participants
Started: Sep 26, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05786222
Permanent Supportive Housing Overdose Prevention
NAEnrolling by invitation
1,350 participants
Started: Sep 26, 2023 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06324578
Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease
N/ARecruiting
150 participants
Started: Sep 25, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05814614
Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation
NARecruiting
150 participants
Started: Sep 25, 2023 · Completed: May 1, 2026
2 conditions3 sponsors1 location
NCT06094231
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
NARecruiting
40 participants
Started: Sep 25, 2023 · Completed: Sep 30, 2025
4 conditions1 sponsor1 location
NCT06105398
the Effect of Core Stability on Hand Functions
N/AActive, not recruiting
94 participants
Started: Sep 25, 2023 · Completed: Dec 25, 2024
1 condition1 sponsor1 location
NCT05936359
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
PHASE1Recruiting
225 participants
Started: Sep 25, 2023 · Completed: Feb 29, 2028
1 condition1 sponsor29 locations